Security key
60770K107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 225,302,088
- Total 13F value
- $86,681,348,769
- Share change
- +17,175,857
- Put/Call ratio
- 116%
- SEC-reported price per share
- $384.86
- Number of holders
- 1,120
- Value change
- +$6,751,024,992
- Number of buys
- 686
- Number of sells
- 375
- Shares outstanding
- 397,148,913
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
1,120
Top holders
10
MRNA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Moderna, Inc. SEC filings
Moderna, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 60770K107
Recent filing periods:
Ownership snapshot
Top reported holders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
12%
VANGUARD GROUP INC
5.1%
BlackRock Finance, Inc.
4.9%
MORGAN STANLEY
1.9%
STATE STREET CORP
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
12%
|
$10,781,638,000
45,883,213 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
5.1%
|
$4,745,398,000
20,194,904 shares
|
— | 30 Jun 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
4.9%
|
$4,556,434,000
19,390,725 shares
|
— | 30 Jun 2021 |
| MORGAN STANLEY |
13F
Company
|
1.9%
|
$1,743,901,000
7,421,497 shares
|
— | 30 Jun 2021 |
| STATE STREET CORP |
13F
Company
|
1.8%
|
$1,721,364,000
7,325,576 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
1.8%
|
$1,695,385,000
7,215,019 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,120
Shares
225,302,088
Rows available
1,120
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
873
Q3 2021 holders
1,120
Holder diff
247
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend